AXIM Biotechnologies, Inc.
OTC: AXIM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Catalina Valencia
- Employees
- 6
- Headquarters
- San Diego, United States
- IPO year
- 2014
- Market cap
- $1.4M
- Website
- https://www.aximbiotech.com
Loading AXIM…
Loading profile data…Frequently asked questions about AXIM
What does AXIM Biotechnologies, Inc. (AXIM) do?
AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential f...
Where does AXIM trade?
AXIM Biotechnologies, Inc. (AXIM) trades on the Other OTC.
What sector is AXIM in?
AXIM Biotechnologies, Inc. (AXIM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of AXIM Biotechnologies, Inc.?
Catalina Valencia is the chief executive officer of AXIM Biotechnologies, Inc. (AXIM).
Where is AXIM Biotechnologies, Inc. headquartered?
AXIM Biotechnologies, Inc. is headquartered in United States.
Does AXIM pay a dividend?
AXIM Biotechnologies, Inc. (AXIM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AXIM go public?
AXIM Biotechnologies, Inc. (AXIM) completed its initial public offering in 2014.